SAN FRANCISCO--(BUSINESS WIRE)--Invitae Corporation (NYSE:NVTA), a genetic information company, presented data on its guidelines-based genetic testing panels at the NCCN Annual Conference: Advancing the Standard of Cancer Care in Hollywood, Florida, on Thursday. Invitae offers guidelines-based panel testing that clinicians can customize to reflect their own diagnoses and expertise to ensure that clinicians have the right tests for the right patients.
